clodronic acid has been researched along with Hypercalcemia in 118 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 47 (39.83) | 18.7374 |
1990's | 52 (44.07) | 18.2507 |
2000's | 16 (13.56) | 29.6817 |
2010's | 2 (1.69) | 24.3611 |
2020's | 1 (0.85) | 2.80 |
Authors | Studies |
---|---|
Kanis, JA; McCloskey, E; Paterson, AH; Powles, T | 1 |
Habib, EE; Sabry, NA | 1 |
Ludwig, H; Zojer, N | 1 |
Cook, R; Major, PP | 1 |
Berenson, JR | 1 |
Ashcroft, AJ; Davies, FE; Morgan, GJ | 1 |
Hanson, J; Neumann, C; Quan, HK; Roemer-Bécuwe, C; Romano, F; Vigano, A; Walker, P | 1 |
Atula, ST; Nevalainen, JI; Pylkkänen, LH; Tähtelä, RK | 1 |
Chou, HC; Hsieh, WS; Hung, SH; Tsai, WY; Tsao, PN | 1 |
Ammann, P; Herter-Clavel, C; Lubrano, A; Rizzoli, R | 1 |
Berenson, J; Hirschberg, R | 1 |
Balla, J | 1 |
Lugassy, G | 1 |
Douglas, DL; Duckworth, T; Kanis, JA; Prenton, MA; Preston, CJ; Preston, FE; Russell, RG; Woodhead, JS | 1 |
Kanis, JA; Mundy, KI; Percival, RC; Preston, CJ; Russell, RG; Yates, AJ | 1 |
Jüngst, D | 1 |
Briançon, D; Chapuy, MC; Charhon, S; Delmas, P; Meunier, PJ; Vignon, E | 1 |
Doppelt, SH; Neer, RM; Nolan, J; Potts, JT; Slovik, DM; Zusman, RM | 1 |
Bonner, EL; Hulter, HN; Ilnicki, LP; Sebastian, A; Toto, RD | 1 |
Bilezikian, JP; Canfield, RE; Jacobs, TP; Shane, E; Siris, ES; Steinberg, SF; Stoddart, K | 1 |
Canfield, RE; Hyman, GA; Siris, ES | 1 |
Kanis, JA; Paterson, AD; Russell, RG | 1 |
Beard, DJ; Cameron, EC; Douglas, DL; Kanis, JA; Paterson, AD; Preston, FE; Russell, RG | 1 |
Chantraine, A; Donath, A; Jung, A; Kitler, ME; Mermillod, B; Turnill, D; van Ouwenaller, C | 1 |
Brown, CB; Guilland-Cumming, D; Hague, RV; Jones, TH; Kanis, JA; Mundy, KI; Yates, AJ | 1 |
Conte, N; Di Virgilio, R; Roiter, I | 1 |
Baron, R; Hayslett, JP; Jaeger, P; Jones, W | 1 |
Delmas, PD; Meunier, PJ | 1 |
D'Souza, SM; Flora, L; Martodam, RR; Mundy, GR; Sica, DA; Thornton, KS | 1 |
Raisz, LG | 1 |
Alexandre, CM; Chapuy, MC; Meunier, PJ; Vignon, EP | 1 |
Baquiran, DC; Bilezikian, JP; Canfield, RE; Jacobs, TP; Shane, E; Siris, ES | 1 |
Chantraine, A; Courvoisier, B; Jung, A; van Ouwenaller, C | 1 |
Jung, A; Miescher, PA; Tschopp, JM | 1 |
Doppelt, SH; Neer, RM; Potts, JT | 1 |
Jung, A | 1 |
Groebli, Y; Hoffmeyer, P; Jung, A; Spiliopoulos, A | 1 |
Kirstein, A; Voigtmann, R | 1 |
Goa, KL; Plosker, GL | 1 |
Anthony, C; Coleman, RE; Kanis, JA; Purohit, OP; Radstone, CR | 1 |
Koyano, H; Schimizu, T; Shishiba, Y | 1 |
Aranko, K; Drake, J; Hanhijärvi, H; Humphreys, M; Lawton, WA | 1 |
Chang, CC; Su, RJ; Tsai, KS | 1 |
Eyres, K; Fern, D; Kanis, JA; McCloskey, EV; O'Rourke, NP; Vasikaran, S | 1 |
Clemens, MR; Fessele, K; Heim, ME | 1 |
Badertscher, E; Ernst, DS; Warnica, JW | 1 |
Krempien, B; Manegold, C | 1 |
Jantunen, E; Laakso, M; Lahtinen, R | 1 |
Kornerup, HJ; Melsen, F; Nielsen, C; Ring, T; Sodemann, B | 1 |
Ralston, SH | 1 |
Kanis, JA | 2 |
Bruera, E; Lawlor, P; Walker, P; Watanabe, S | 1 |
Ashley, S; Hanson, J; Kanis, JA; McCloskey, E; Paterson, AH; Powles, TJ | 1 |
Bauduer, F; Delmer, A | 1 |
Adam, Z; Hájek, D; Hejlová, N; Krejcí, M; Prokes, B; Vorlícek, J; Znojĭl, V | 1 |
Coleman, RE; Eastell, R; Guo, CY; Purohit, OP; Vinholes, J | 1 |
Body, JJ; Coleman, RE; Piccart, M | 1 |
Paterson, AH | 1 |
Bruera, E; Hanson, J; Lawlor, P; Pereira, J; Walker, P; Watanabe, S | 1 |
Chapman, C; Drayson, MT; Dunn, J; Kanis, JA; MacLennan, IC; McCloskey, EV | 1 |
Jensen, JE; Sørensen, HA; Sørensen, OH | 1 |
Kalliovalkama, J; Kankaanranta, H; Lähteenmäki, T; Pörsti, I; Salenius, JP; Sisto, T; Wu, X; Ylitalo, P; Ylitalo, R | 1 |
Bartl, R; Body, JJ; Burckhardt, P; Delmas, PD; Diel, IJ; Fleisch, H; Kanis, JA; Kyle, RA; Mundy, GR; Paterson, AH; Rubens, RD | 1 |
Musto, P | 1 |
Elo, HA; Holli, K; Juhakoski, A; Liukko-Sipi, S; Mönkkönen, J; Ylitalo, P; Ylitalo, R | 1 |
Berthaud, P; Jadaud, E; Lortholary, A | 1 |
Filella, X; Font, J; Grau, JM; Martínez de Osaba, MJ; Muñoz-Gómez, J; Peris, P | 1 |
Ranganath, L; Semple, MJ | 1 |
Kanis, JA; McCloskey, EV | 1 |
Body, JJ | 1 |
Finardi, G; Garzaniti, A; Gazzaruso, C; Geroldi, D; Montecucco, CM | 1 |
Bastert, G; Diel, IJ; Solomayer, EF | 1 |
A'Hern, R; Broadley, K; Davis, C; Gwilliam, B; Hardy, J; Ling, J; Rees, E; Shah, S | 1 |
Elomaa, I; Laakso, M; Lahtinen, R; Palva, I; Virkkunen, P | 1 |
Henning, HV; Warneke, G | 1 |
Atkinson, AB; Crowe, G; McCance, DR; Rankin, SJ; Spedding, R | 1 |
Evald, T; Garde, K; Jensen, GV | 1 |
Bandmann, U; Eriksson, M; Glas, U; Hansen, J; Pfeiffer, P; Rotstein, S; Söderqvist, J; Strid, S | 1 |
Liippo, K; Puolijoki, H | 1 |
Bonjour, JP; Buchs, B; Rizzoli, R | 1 |
Conti, F; Francini, G; Gennari, C; Gonnelli, S; Paffetti, P; Petrioli, R | 1 |
Ashley, S; Ernst, DS; Kanis, JA; McCloskey, EV; Paterson, AH; Powles, TJ | 1 |
Biermann, WA; Cantor, RI; Fellin, FM; Hopkins, L; Jakobowski, J; Newbold, RC | 1 |
Coleman, RE | 1 |
Beuzeboc, P; Pouillart, P | 1 |
Bonjour, JP; Rizzoli, R | 2 |
Delmas, PD | 1 |
Kanis, JA; McCloskey, EV; Paterson, AH | 1 |
Boyle, IT; Dryburgh, FJ; Fraser, WD; Gallacher, SJ; Patel, U; Ralston, SH | 1 |
Rostom, AY | 1 |
Fritze, D; Harjung, H | 1 |
Caulin, F | 1 |
Warrell, RP | 2 |
Decker, JE; Lorenzo, JA; McCarron, BA; Morrison, NE; Raisz, LG; Samour, CM | 1 |
Ljunghall, S | 1 |
Scharla, SH; Ziegler, R | 1 |
Ascari, E; Attardo-Parrinello, G; Merlini, G | 1 |
Bonjour, JP; Caverzasio, J; Hirschel-Scholz, S; Rizzoli, R | 1 |
Baruffi, C; Conte, N; Di Virgilio, R; Foscolo, G; Roiter, I | 1 |
Bijvoet, OL; Cleton, FJ; Elte, JW; Sleeboom, HP; van Oosterom, AT | 1 |
Benson, AB; Citrin, DL; Davis, TE; Durie, BG; Jacobs, TP; Koeller, J; Lipton, A; Stock, JL; Witte, RS | 1 |
Akerström, G; Benson, L; Johansson, H; Knuutila, M; Ljunghall, S; Pettersson, B; Rastad, J; Wallfelt, C | 1 |
Blind, E; Ho, T; Mende, U; Minne, HW; Sattar, P; Scharla, SH; Schmidt-Gayk, H; Wüster, C; Ziegler, R | 1 |
Peck, WA | 1 |
Gray, RE; Greaves, M; Hamdy, NA; Kanis, JA; McCloskey, EV; Neil, FE; Preston, FE; Urwin, GH; Yates, AJ | 1 |
Canfield, RE; Jacobs, TP; Siris, ES | 1 |
Brown, CB; Galloway, J; Gray, RE; Hamdy, NA; Kanis, JA; McCloskey, E; Rattenbury, JM | 1 |
Akerström, G; Ljunghall, S; Rastad, J | 1 |
Lind, L; Ljunghall, S; Wengle, B | 1 |
Bisetti, A; Bonjour, JP; Guelpa, G; Jung, A; Kanis, JA; Philippe, J; Rizzoli, R; Rosini, S | 1 |
Barrett, PQ; Insogna, KL; Sartori, L | 1 |
Adami, S; Bertoldo, F; Bolzicco, GP; Lo Cascio, V; Rizzo, A; Rossini, M; Salvagno, G; Suppi, R | 1 |
Caberlotto, L; Conte, N; Di Virgilio, R; Roiter, I | 1 |
Beard, DJ; Douglas, DL; Kanis, JA; Neal, FE; Paterson, AD; Percival, RC; Russell, RG; Yates, AJ | 1 |
Fleisch, H | 1 |
30 review(s) available for clodronic acid and Hypercalcemia
Article | Year |
---|---|
Supportive therapy in multiple myeloma.
Topics: Anemia; Blood Transfusion; Bone Diseases; Calcitonin; Clodronic Acid; Diphosphonates; Erythropoietin; Fractures, Bone; Hematinics; Humans; Hypercalcemia; Imidazoles; Multiple Myeloma; Osteoporosis; Pamidronate; Recombinant Proteins; Renal Insufficiency; Zoledronic Acid | 2011 |
Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints.
Topics: Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Data Interpretation, Statistical; Diphosphonates; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Imidazoles; Male; Models, Statistical; Pain; Pamidronate; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Spinal Cord Compression; Treatment Outcome; Zoledronic Acid | 2002 |
Treatment of hypercalcemia of malignancy with bisphosphonates.
Topics: Bone Resorption; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Neoplasms; Pamidronate; Zoledronic Acid | 2002 |
Aetiology of bone disease and the role of bisphosphonates in multiple myeloma.
Topics: Antineoplastic Agents; Bone and Bones; Bone Density; Bone Neoplasms; Chemokines; Clinical Trials as Topic; Clodronic Acid; Cytokines; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Multiple Myeloma; Osteolysis; Patient Selection; Treatment Outcome; Zoledronic Acid | 2003 |
Safety and convenience of a 15-minute infusion of zoledronic acid.
Topics: Antineoplastic Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Pamidronate; Time Factors; Zoledronic Acid | 2004 |
Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
Topics: Animals; Bone Neoplasms; Bone Resorption; Calcinosis; Clinical Trials as Topic; Clodronic Acid; Dose-Response Relationship, Drug; Half-Life; Humans; Hydroxyproline; Hypercalcemia; Infusions, Intravenous; Metabolic Clearance Rate; Neoplasms; Osteitis Deformans; Osteoporosis; Tissue Distribution | 1994 |
Use of clodronate in multiple myeloma.
Topics: Antimetabolites; Bone Diseases; Clodronic Acid; Controlled Clinical Trials as Topic; Humans; Hypercalcemia; Multicenter Studies as Topic; Multiple Myeloma; Osteolysis | 1995 |
Pathogenesis and management of cancer associated hypercalcaemia.
Topics: Antineoplastic Agents; Calcitonin; Calcium; Clodronic Acid; Diphosphonates; Diuretics; Etidronic Acid; Fluid Therapy; Gallium; Humans; Hypercalcemia; Neoplasms; Pamidronate; Phosphates; Plicamycin; Research | 1994 |
Bone and cancer: pathophysiology and treatment of metastases.
Topics: Analgesics, Non-Narcotic; Bone and Bones; Bone Diseases, Metabolic; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Humans; Hypercalcemia; Pain; Pamidronate; Parathyroid Hormone | 1995 |
[Multiple myeloma and bone manifestations. Role of clodronate].
Topics: Analgesics, Non-Narcotic; Bone Density; Bone Diseases; Clodronic Acid; Humans; Hypercalcemia; Magnetic Resonance Imaging; Multiple Myeloma; Osteolysis; Pain; Quality of Life; Radiography; Treatment Outcome | 1996 |
Use of bisphosphonates in cancer patients.
Topics: Alendronate; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Multiple Myeloma; Osteolysis; Pain; Pamidronate; Structure-Activity Relationship | 1996 |
Rationale for the use of bisphosphonates in breast cancer.
Topics: Bone Neoplasms; Bone Remodeling; Breast Neoplasms; Clodronic Acid; Cost-Benefit Analysis; Diphosphonates; Fractures, Spontaneous; Humans; Hypercalcemia; Osteoclasts; Pain; Pamidronate; Quality of Life | 1996 |
Should bisphosphonates be standard therapy for bone pain?
Topics: Analgesics, Non-Narcotic; Bone Neoplasms; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Male; Pain | 1997 |
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
Topics: Analgesics, Non-Narcotic; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Multiple Myeloma; Pain; Pamidronate | 1998 |
The role of bisphosphonates for the treatment of bone disease in multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Bone Remodeling; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; Hypercalcemia; Male; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Osteolysis; Palliative Care; Pamidronate; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome | 1998 |
[Bisphosphonates and bone metastases].
Topics: Antineoplastic Agents; Bone Diseases; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Male; Multiple Myeloma; Pain; Pamidronate; Prostatic Neoplasms; Randomized Controlled Trials as Topic | 1999 |
Bisphosphonates in multiple myeloma.
Topics: Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Multiple Myeloma; Pain; Pamidronate | 2000 |
Current and future directions in medical therapy: hypercalcemia.
Topics: Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Neoplasms; Pamidronate; Zoledronic Acid | 2000 |
Treatment of metastatic bone disease in breast cancer: bisphosphonates.
Topics: Analgesics, Non-Narcotic; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Fractures, Spontaneous; Humans; Hypercalcemia; Incidence; Pain; Pamidronate; Patient Selection; Survival Analysis; Treatment Outcome | 2000 |
[Bisphosphonates. Drugs for the treatment of disorders of calcium and bone metabolism].
Topics: Bone Neoplasms; Calcium; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Osteoporosis; Structure-Activity Relationship | 1992 |
Treatment of skeletal disease in breast cancer with clodronate.
Topics: Administration, Oral; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Combined Modality Therapy; Double-Blind Method; Fractures, Spontaneous; Humans; Hypercalcemia; Incidence; Injections, Intravenous; Osteolysis; Pain; Palliative Care; Prospective Studies; Spinal Fractures; Treatment Outcome | 1991 |
An evaluation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone.
Topics: Ambulatory Care; Analgesics; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Cost-Benefit Analysis; Costs and Cost Analysis; Epidural Space; Fractures, Spontaneous; Hospitalization; Hospitals, University; Humans; Hypercalcemia; Incidence; Length of Stay; Osteolysis; Outpatient Clinics, Hospital; Pain; Palliative Care; Philadelphia; Radiotherapy; Retrospective Studies; Spinal Neoplasms | 1991 |
Treatment of hypercalcaemia of malignancy with clodronate.
Topics: Calcium; Clodronic Acid; Homeostasis; Humans; Hypercalcemia; Neoplasms; Osteoclasts; Osteolysis | 1991 |
The use of clodronate in multiple myeloma.
Topics: Antineoplastic Agents; Bone Resorption; Calcium; Clodronic Acid; Combined Modality Therapy; Double-Blind Method; Humans; Hypercalcemia; Lymphokines; Multiple Myeloma; Neoplasm Proteins; Osteoclasts; Osteolysis | 1991 |
Clodronate in hypercalcemia of malignancy.
Topics: Animals; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Paraneoplastic Syndromes | 1990 |
Hypercalcemia and bone metastases in breast cancer.
Topics: Alendronate; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Hypercalcemia; Neoplasm Proteins; Pamidronate; Parathyroid Hormone-Related Protein; Proteins; Transforming Growth Factors | 1990 |
Use of clodronate and calcitonin in hypercalcemia due to malignancy.
Topics: Calcitonin; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Neoplasms | 1989 |
Management of hypercalcemia in relation to pathophysiology.
Topics: Amifostine; Bone Resorption; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Organothiophosphorus Compounds | 1987 |
Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and bisphosphonate treatment.
Topics: Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clodronic Acid; Diagnosis, Differential; Diphosphonates; Female; Humans; Hypercalcemia; Hyperparathyroidism; Osteolysis | 1986 |
[Biphosphonate as a therapeutic drug--experimental studies and clinical application].
Topics: Animals; Calcinosis; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Hyperparathyroidism; Myositis Ossificans; Osteitis Deformans; Osteolysis; Osteoporosis; Pamidronate; Urinary Calculi | 1985 |
22 trial(s) available for clodronic acid and Hypercalcemia
Article | Year |
---|---|
Zoledronic acid and clodronate in the treatment of malignant bone metastases with hypercalcaemia; efficacy and safety comparative study.
Topics: Adolescent; Adult; Bone Density Conservation Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Imidazoles; Male; Middle Aged; Young Adult; Zoledronic Acid | 2011 |
Clodronate as a single-dose intravenous infusion effectively provides short-term correction of malignant hypercalcemia.
Topics: Calcium; Clodronic Acid; Diphosphonates; Double-Blind Method; Female; Humans; Hypercalcemia; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Pamidronate | 2003 |
[Dichloromethylene diphosphonate (Cl2MDP) treatment of hypercalcaemia produced from bone metastases (author's transl)].
Topics: Adult; Aged; Bone Neoplasms; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Double-Blind Method; Female; Humans; Hypercalcemia; Male; Middle Aged | 1982 |
Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton.
Topics: Administration, Oral; Adult; Aged; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcium; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Double-Blind Method; Female; Humans; Hydroxyproline; Hypercalcemia; Middle Aged; Osteoclasts | 1983 |
Use of dichloromethylene diphosphonate in metastatic bone disease.
Topics: Bone Neoplasms; Bone Resorption; Calcium; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Double-Blind Method; Humans; Hypercalcemia; Multiple Myeloma; Osteolysis; Random Allocation | 1983 |
A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
Topics: Bone Neoplasms; Bone Resorption; Clodronic Acid; Diphosphonates; Double-Blind Method; Humans; Hypercalcemia; Pamidronate; Treatment Outcome | 1995 |
Beneficial effects of oral clodronate in the management of malignant osteolysis and hypercalcaemia.
Topics: Biological Availability; Clodronic Acid; Cross-Over Studies; Double-Blind Method; Humans; Hypercalcemia; Osteolysis; Prospective Studies; Therapeutic Equivalency | 1995 |
Multiple myeloma: effect of daily dichloromethylene bisphosphonate on skeletal complications.
Topics: Adult; Aged; Analgesia; Bone Diseases; Bone Resorption; Calcium; Clodronic Acid; Female; Fractures, Bone; Humans; Hypercalcemia; Male; Melphalan; Middle Aged; Multiple Myeloma; Osteoporosis; Prednisolone; Prospective Studies | 1993 |
Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Biomarkers; Bone Neoplasms; Bone Resorption; Calcium; Clodronic Acid; Collagen; Collagen Type I; Diphosphonates; Double-Blind Method; Female; Humans; Hydroxyproline; Hypercalcemia; Male; Middle Aged; Pamidronate; Parathyroid Hormone; Peptides | 1997 |
A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. MRC Working Party on Leukaemia in Adults.
Topics: Aged; Analgesics, Non-Narcotic; Bone Diseases; Calcium; Clodronic Acid; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Hypocalcemia; Male; Middle Aged; Multiple Myeloma; Pain; Treatment Outcome | 1998 |
Comparison of pharmacokinetics of clodronate after single and repeated doses.
Topics: Adult; Aged; Bone Neoplasms; Clodronic Acid; Cross-Over Studies; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypercalcemia; Male; Middle Aged; Reference Values | 1999 |
Is there a dose response relationship for clodronate in the treatment of tumour induced hypercalcaemia?
Topics: Adult; Aged; Aged, 80 and over; Calcium; Clodronic Acid; Dose-Response Relationship, Drug; Female; Humans; Hypercalcemia; Male; Middle Aged; Neoplasms | 2002 |
Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Diseases; Calcium; Clodronic Acid; Double-Blind Method; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Hypercalcemia; Male; Middle Aged; Multiple Myeloma; Pain; Placebos | 1992 |
Intravenous clodronate for the treatment of hypercalcaemia in breast cancer patients with bone metastases--a prospective randomised placebo-controlled multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Blood Proteins; Bone Neoplasms; Breast Neoplasms; Calcium; Clodronic Acid; Double-Blind Method; Female; Fluid Therapy; Humans; Hydroxyproline; Hypercalcemia; Hypocalcemia; Infusions, Intravenous; Middle Aged; Placebos; Prospective Studies | 1992 |
Effect of a single infusion of alendronate in malignant hypercalcaemia: dose dependency and comparison with clodronate.
Topics: Aged; Alendronate; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Hypercalcemia; Male; Middle Aged; Neoplasms | 1992 |
Treatment of bone metastases with dichloromethylene bisphosphonate.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Calcium; Chemotherapy, Adjuvant; Clodronic Acid; Drug Administration Schedule; Female; Humans; Hypercalcemia; Male | 1992 |
Treatment of skeletal disease in breast cancer with clodronate.
Topics: Administration, Oral; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Combined Modality Therapy; Double-Blind Method; Fractures, Spontaneous; Humans; Hypercalcemia; Incidence; Injections, Intravenous; Osteolysis; Pain; Palliative Care; Prospective Studies; Spinal Fractures; Treatment Outcome | 1991 |
The use of clodronate in multiple myeloma.
Topics: Antineoplastic Agents; Bone Resorption; Calcium; Clodronic Acid; Combined Modality Therapy; Double-Blind Method; Humans; Hypercalcemia; Lymphokines; Multiple Myeloma; Neoplasm Proteins; Osteoclasts; Osteolysis | 1991 |
Hypercalcemia and bone metastases in breast cancer.
Topics: Alendronate; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Hypercalcemia; Neoplasm Proteins; Pamidronate; Parathyroid Hormone-Related Protein; Proteins; Transforming Growth Factors | 1990 |
Clodronate. A randomized study in the treatment of cancer-related hypercalcemia.
Topics: Adult; Aged; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Double-Blind Method; Female; Humans; Hypercalcemia; Male; Middle Aged; Neoplasms; Random Allocation; Saline Solution, Hypertonic | 1987 |
Results of a randomized study of clodronate in treating cancer-related hypercalcemia.
Topics: Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Leukemia; Neoplasms; Random Allocation | 1987 |
Dichloromethylene diphosphonate action in hematologic and other malignancies.
Topics: Administration, Oral; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyproline; Hypercalcemia; Infusions, Intravenous; Leukemia, Lymphoid; Male; Multiple Myeloma; Neoplasms; Pain | 1987 |
69 other study(ies) available for clodronic acid and Hypercalcemia
Article | Year |
---|---|
Clodronate.
Topics: Animals; Clodronic Acid; Diphosphonates; Hypercalcemia; Mice; Osteitis Deformans; Osteoclasts | 2021 |
Safety of subcutaneous clodronate and efficacy in hypercalcemia of malignancy: a novel route of administration.
Topics: Analgesics, Non-Narcotic; Clodronic Acid; Cohort Studies; Female; Humans; Hypercalcemia; Injections, Subcutaneous; Male; Neoplasms; Retrospective Studies; Treatment Outcome | 2003 |
Oral clodronate therapy for hypercalcemia related to extensive subcutaneous fat necrosis in a newborn.
Topics: Administration, Oral; Antimetabolites; Clodronic Acid; Fat Necrosis; Female; Humans; Hypercalcemia; Infant, Newborn | 2003 |
A single bisphosphonate infusion is associated with improved functional capacity in elderly subjects with primary hyperparathyroidism.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antimetabolites; Bone and Bones; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Hyperparathyroidism; Male; Pamidronate; Retrospective Studies; Treatment Outcome | 2003 |
The issue of renal safety of zoledronic acid from a nephrologist's point of view.
Topics: Antineoplastic Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Pamidronate; Time Factors; Zoledronic Acid | 2005 |
"Safety and convenience of a 15-minute infusion of zoledronic acid": not so safe.
Topics: Antineoplastic Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Pamidronate; Time Factors; Zoledronic Acid | 2005 |
Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.
Topics: Alkaline Phosphatase; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Humans; Hydroxyproline; Hypercalcemia; Hyperparathyroidism; Neoplasms; Osteitis Deformans | 1980 |
Effects of intravenous diphosphonates on renal function.
Topics: Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Injections, Intravenous; Kidney; Methylene Chloride; Organophosphorus Compounds | 1983 |
Disodium clodronate effective in management of severe hypercalcaemia caused by parathyroid carcinoma.
Topics: Acute Disease; Carcinoma; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Middle Aged; Parathyroid Neoplasms | 1984 |
Gut-mediated hypercalcemia in rabbits bearing VX2 carcinoma: new mechanism for tumor-induced hypercalcemia.
Topics: Animals; Carcinoma; Clodronic Acid; Hypercalcemia; Indomethacin; Male; Neoplasms, Experimental; Prostaglandins E; Rabbits | 1982 |
Renal and systemic acid-base effects of the chronic administration of hypercalcemia-producing agents: calcitriol, PTH, and intravenous calcium.
Topics: Acid-Base Equilibrium; Acids; Animals; Bicarbonates; Calcitriol; Calcium; Clodronic Acid; Dogs; Female; Hypercalcemia; Parathyroid Glands; Parathyroid Hormone; Thyroidectomy | 1982 |
Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate.
Topics: Aged; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Infusions, Parenteral; Male; Middle Aged; Parathyroid Neoplasms | 1982 |
The use of diphosphonates in myeloma.
Topics: Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Multiple Myeloma | 1983 |
The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma.
Topics: Aged; Alkaline Phosphatase; Calcium; Clodronic Acid; Creatinine; Diphosphonates; Female; Humans; Hydroxyproline; Hypercalcemia; Male; Middle Aged; Multiple Myeloma; Osteitis Deformans | 1983 |
Immobilisation hypercalcaemia in adults and treatment with clodronate.
Topics: Adult; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Immobilization; Time Factors | 1984 |
[Hypercalcemic crises of myelomatous origin. Treatment with dichloromethylene diphosphonate].
Topics: Aged; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Male; Multiple Myeloma; Paraneoplastic Syndromes | 1984 |
Modulation of hypercalcemia by dichloromethane diphosphonate and by calcitonin in a model of chronic primary hyperparathyroidism in rats.
Topics: Animals; Calcitonin; Clodronic Acid; Diphosphonates; Hypercalcemia; Hyperparathyroidism; Male; Parathyroid Hormone; Rats; Rats, Inbred Strains; Thyroidectomy | 1984 |
[Diphosphonates in the treatment of hypercalcemia].
Topics: Bone Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Hyperparathyroidism; Pamidronate | 1984 |
The effects of dichloromethylene diphosphonate on hypercalcemia and other parameters of the humoral hypercalcemia of malignancy in the rat Leydig cell tumor.
Topics: Animals; Bone Resorption; Calcium; Clodronic Acid; Cyclic AMP; Diphosphonates; Hypercalcemia; Leydig Cell Tumor; Male; Neoplasms, Experimental; Osteoblasts; Osteoclasts; Phosphorus; Rats; Rats, Inbred F344; Testicular Neoplasms | 1983 |
New diphosphonates to block bone resorption.
Topics: Animals; Bone Resorption; Breast Neoplasms; Clodronic Acid; Diphosphonates; Double-Blind Method; Etidronic Acid; Humans; Hypercalcemia; Hyperparathyroidism; Multiple Myeloma; Osteitis Deformans; Osteoclasts; Osteolysis; Osteomalacia; Propanolamines | 1980 |
Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
Topics: Adult; Aged; Bone Neoplasms; Clodronic Acid; Diphosphonates; Double-Blind Method; Female; Humans; Hypercalcemia; Male; Middle Aged; Paraplegia; Pilot Projects | 1980 |
Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate.
Topics: Adult; Aged; Bone Neoplasms; Bone Resorption; Calcium; Clodronic Acid; Diarrhea; Diphosphonates; Drug Administration Schedule; Female; Humans; Hydroxyproline; Hypercalcemia; Hypocalcemia; Kidney Tubules; Male; Middle Aged; Necrosis | 1981 |
Parenteral diphosphonates for treating malignant hypercalcemia.
Topics: Aged; Bone Neoplasms; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Drug Administration Schedule; Etidronic Acid; Female; Humans; Hypercalcemia; Infusions, Parenteral; Male; Middle Aged; Time Factors | 1981 |
[Suppression of severe hypocalcemia associated with malignant lymphoma by intravenous administration of dichloromethylene diphosphonate].
Topics: Adult; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Injections, Intravenous; Lymphoma; Male | 1981 |
Human parathyroid hormone 1-34-mediated hypercalcemia in a rat model, and its inhibition by dichloromethane diphosphonate.
Topics: Animals; Calcium; Clodronic Acid; Diphosphonates; Disease Models, Animal; Hypercalcemia; Kinetics; Parathyroid Glands; Parathyroid Hormone; Peptide Fragments; Phosphates; Rats; Teriparatide; Thyroidectomy | 1981 |
Comparison of two parenteral diphosphonates in hypercalcemia of malignancy.
Topics: Adult; Aged; Bone Neoplasms; Calcium; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Injections, Intravenous; Male; Middle Aged | 1982 |
[[Clodronate therapy of hypercalcemia caused by hyperparathyroidism].
Topics: Aged; Clodronic Acid; Diphosphonates; Drug Evaluation; Female; Humans; Hypercalcemia; Hyperparathyroidism; Male; Middle Aged | 1982 |
[Clodronate in treatment of tumor osteopathy. Evaluation in tumor patients with bone metastases or hypercalcemia].
Topics: Adult; Aged; Bone Neoplasms; Clodronic Acid; Female; Humans; Hypercalcemia; Male; Middle Aged; Pain Measurement; Palliative Care; Paraneoplastic Syndromes; Quality of Life | 1994 |
The bisphosphonate dilemma.
Topics: Alendronate; Bone and Bones; Bone Neoplasms; Clodronic Acid; Diphosphonates; False Negative Reactions; Female; Humans; Hypercalcemia; Middle Aged; Parathyroid Neoplasms; Radionuclide Imaging; Technetium Tc 99m Medronate | 1995 |
Plasma PTH and PTH-rP levels and clodronate therapy in cancer patients with hypercalcemia.
Topics: Clodronic Acid; Humans; Hypercalcemia; Neoplasms; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Proteins | 1993 |
Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate.
Topics: Adult; Aged; Calcium; Clodronic Acid; Drug Administration Schedule; Female; Humans; Hypercalcemia; Infusions, Intravenous; Male; Middle Aged; Neoplasms | 1993 |
Acute hypercalcemia and severe bradycardia in a patient with breast cancer.
Topics: Adult; Bradycardia; Breast Neoplasms; Calcitonin; Clodronic Acid; Electrocardiography; Female; Humans; Hypercalcemia | 1993 |
Prophylactic treatment of skeletal metastases, tumor-induced osteolysis, and hypercalcemia in rats with the bisphosphonate Cl2MBP.
Topics: Animals; Bone Neoplasms; Carcinoma 256, Walker; Clodronic Acid; Diphosphonates; Drug Administration Schedule; Drug Screening Assays, Antitumor; Hypercalcemia; Male; Osteolysis; Rats; Rats, Wistar; Tibia | 1993 |
Mineralization defect but no effect on hypercalcemia during clodronate treatment in secondary hyperparathyroidism.
Topics: Adult; Aged; Calcification, Physiologic; Calcium; Clodronic Acid; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Infusions, Intravenous; Male; Middle Aged; Uremia | 1995 |
Subcutaneous clodronate.
Topics: Aged; Analgesics, Non-Narcotic; Clodronic Acid; Humans; Hypercalcemia; Infusions, Parenteral; Male; Middle Aged | 1996 |
Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
Topics: Analgesics, Non-Narcotic; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Hypercalcemia; Multiple Myeloma; Osteoporosis; Pain; Pamidronate | 1995 |
[The effect of clodronate on bone density in patients with multiple myeloma--a 2-year follow-up of therapeutic effects].
Topics: Adult; Aged; Bone Density; Clodronic Acid; Diphosphonates; Female; Follow-Up Studies; Humans; Hypercalcemia; Male; Middle Aged; Multiple Myeloma; Osteolysis | 1996 |
Subcutaneous clodronate: a study evaluating efficacy in hypercalcemia of malignancy and local toxicity.
Topics: Aged; Aged, 80 and over; Clodronic Acid; Female; Humans; Hypercalcemia; Injections, Subcutaneous; Male; Middle Aged; Neoplasms | 1997 |
[Hypercalcemia--diagnosis and treatment].
Topics: Calcitonin; Calcium; Calcium Channel Blockers; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Parathyroid Hormone; Prednisolone; Reference Values | 1998 |
Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro.
Topics: Animals; Arteries; Calcium Channel Blockers; Clodronic Acid; Diphosphonates; Drug Synergism; Etidronic Acid; Humans; Hypercalcemia; In Vitro Techniques; Male; Nifedipine; Osteoporosis; Pamidronate; Rats; Rats, Wistar; Vasoconstriction | 1998 |
Calcitriol-mediated hypercalcaemia and increased interleukins in a patient with sarcoid myopathy.
Topics: Antirheumatic Agents; Calcitonin; Calcitriol; Chloroquine; Clodronic Acid; Female; Humans; Hypercalcemia; Interleukin-6; Interleukins; Middle Aged; Muscle Weakness; Prednisolone; Sarcoidosis; Sjogren's Syndrome; Tumor Necrosis Factor-alpha | 1999 |
Hypercalcaemia in a 63 year old man.
Topics: Anti-Inflammatory Agents; Calcium-Binding Proteins; Clodronic Acid; Diphosphonates; Drug Resistance; Humans; Hypercalcemia; Male; Middle Aged; Multiple Myeloma | 2000 |
Severe hypercalcemia and systemic lupus erythematosus.
Topics: Adult; Azathioprine; Blood Sedimentation; Clodronic Acid; Female; Humans; Hypercalcemia; Lupus Erythematosus, Systemic; Methylprednisolone; Prednisone; Radiography, Thoracic | 2000 |
Severe hypercalcaemia four months after acute oliguric renal failure--successful treatment with intravenous clodronate.
Topics: Acute Kidney Injury; Adult; Clodronic Acid; Humans; Hypercalcemia; Infusions, Intravenous; Male; Oliguria; Time Factors | 1992 |
[Hypercalcemia during immobilization and prolonged anuria treated with disodium clodronate].
Topics: Accidents, Traffic; Adult; Anuria; Clodronic Acid; Humans; Hypercalcemia; Immobilization; Male | 1992 |
Symptomatic hypercalcaemia in lung cancer.
Topics: Aged; Clodronic Acid; Humans; Hypercalcemia; Lung Neoplasms; Male; Middle Aged; Pilot Projects | 1992 |
Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy.
Topics: Animals; Bone and Bones; Bone Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Neoplasms; Pamidronate | 1991 |
[Value of Clodronate in the treatment of bone metastasis].
Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Female; Humans; Hypercalcemia; Male; Osteolysis; Prostatic Neoplasms | 1991 |
Use of diphosphonates in hypercalcaemia due to malignancy.
Topics: Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Neoplasms | 1990 |
Use of bisphosphonates in hypercalcaemia due to malignancy.
Topics: Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Neoplasms; Pamidronate | 1990 |
Clodronate as outpatient treatment for hypercalcaemia.
Topics: Clodronic Acid; Humans; Hypercalcemia; Reference Values | 1990 |
[Monotherapy with clodronate for tumor-induced hypercalcemia].
Topics: Aged; Breast Neoplasms; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Leiomyosarcoma; Lung Neoplasms; Male; Middle Aged; Neoplasms; Pancreatic Neoplasms; Plasmacytoma; Uterine Neoplasms | 1990 |
[Role and use of biphosphonates in the treatment of metastatic breast cancer].
Topics: Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Female; Humans; Hypercalcemia; Organophosphonates; Osteolysis | 1990 |
The effects of thionapthene-2-carboxylic acid-lysine on the hypercalcemia of malignancy in the rat.
Topics: Animals; Bone Resorption; Calcium; Clodronic Acid; Hypercalcemia; Leydig Cell Tumor; Lysine; Male; Rats; Rats, Inbred F344; Thiophenes | 1989 |
Treatment of tumor hypercalcemia with clodronate.
Topics: Administration, Oral; Adult; Aged; Calcitriol; Calcium; Clodronic Acid; Creatinine; Diphosphonates; Drug Evaluation; Humans; Hypercalcemia; Infusions, Intravenous; Middle Aged; Neoplasms; Parathyroid Hormone | 1989 |
Treatment of painful bone lesions and hypercalcemia.
Topics: Bone Diseases; Clodronic Acid; Diphosphonates; Drug Evaluation; Humans; Hypercalcemia; Multiple Myeloma; Pain; Pilot Projects | 1989 |
[Neoplastic hypercalcemia with renal insufficiency: treatment with dichloromethylene diphosphonate].
Topics: Adult; Aged; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Kidney Diseases; Male; Middle Aged; Paraneoplastic Syndromes | 1985 |
Clodronate treatment in patients with malignancy-associated hypercalcemia.
Topics: Administration, Oral; Adult; Aged; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Injections, Intravenous; Male; Middle Aged; Neoplasms | 1987 |
[Treatment of tumor hypercalcemia with clodronate. Effect on parathormone and calcitriol].
Topics: Adult; Aged; Calcitriol; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Male; Middle Aged; Neoplasms; Parathyroid Hormone | 1987 |
Treatment of the hypercalcaemia of malignancy with intravenous clodronate.
Topics: Adult; Aged; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyproline; Hypercalcemia; Infusions, Intravenous; Kidney Tubules; Leukemia; Male; Middle Aged; Neoplasms | 1987 |
Clodronate in the medical management of hyperparathyroidism.
Topics: Administration, Oral; Bone Resorption; Clodronic Acid; Diphosphonates; Humans; Hydroxyproline; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Infusions, Intravenous | 1987 |
Comparative effects of calcitonin and clodronate in hypercalcaemia.
Topics: Administration, Oral; Calcitonin; Clodronic Acid; Diphosphonates; Follow-Up Studies; Humans; Hypercalcemia; Infusions, Intravenous; Neoplasms; Time Factors | 1987 |
Treatment with clodronate in patients with hypercalcemia secondary to malignancy.
Topics: Adult; Aged; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Male; Middle Aged; Neoplasms | 1987 |
Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate.
Topics: Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Kidney Tubules; Neoplasms | 1988 |
Renal phosphate transport in humoral hypercalcemia of malignancy.
Topics: Alkaline Phosphatase; Animals; Calcium; Clodronic Acid; Hypercalcemia; Kidney; Kinetics; Leydig Cell Tumor; Male; Microvilli; Phosphates; Rats; Rats, Inbred F344; Reference Values | 1988 |
The use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemia of malignancy.
Topics: Administration, Oral; Adult; Aged; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Infusions, Intravenous; Injections, Intramuscular; Male; Middle Aged; Neoplasms; Recurrence | 1987 |
New inhibitors of osteolysis: implications for hypercalcemia and bone metastases.
Topics: Amifostine; Bone Neoplasms; Bone Resorption; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Osteolysis; Pamidronate; Plicamycin | 1986 |
Hypercalcemia in malignancies: treatment with dichloromethylene diphosphonate (Cl2MDP).
Topics: Adult; Aged; Bone Neoplasms; Calcium; Clodronic Acid; Diphosphonates; Drug Evaluation; Female; Humans; Hydroxyproline; Hypercalcemia; Male; Middle Aged; Neoplasms; Time Factors | 1985 |
Treatment of malignant hypercalcaemia with clodronate.
Topics: Adult; Aged; Alkaline Phosphatase; Bone Neoplasms; Calcium; Clodronic Acid; Creatinine; Diphosphonates; Female; Humans; Hypercalcemia; Male; Middle Aged; Osteolysis | 1985 |